This article highlights recent developments in GLP-1 agonist formulations and delivery methods, including advanced injectable formulations (eg, prolonged release), novel oral delivery systems (eg, buccal tablets), and topical formulations (eg, transdermal patches)
Some researchers investigate topical delivery methods in relevant study contexts
When medications are tolerated more comfortably, dose adjustments become easier to sustain over time, which is important for long-term metabolic outcomes
References Dennis A, Wamil M, Alberts J, Oben J, Cuthbertson DJ, Wootton D, et al
Blue Cross and Blue Shield of Texas (BCBSTX) will now offer health care coverage options for Medicare-eligible individuals in 38 new counties, as well as add multiple lower-cost plans in 2023